1 Study Coverage 1.1 Inhaled Antibiotics Product Introduction 1.2 Market by Type 1.2.1 Global Inhaled Antibiotics Market Size Growth Rate by Type 1.2.2 Nebulized 1.2.3 Dry Powder 1.3 Market by Application 1.3.1 Global Inhaled Antibiotics Market Size Growth Rate by Application 1.3.2 Ventilator-associated Pneumonia 1.3.3 Ventilator-associated Bronchitis 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Inhaled Antibiotics Market Size, Estimates and Forecasts 2.1.1 Global Inhaled Antibiotics Revenue 2016-2027 2.1.2 Global Inhaled Antibiotics Sales 2016-2027 2.2 Global Inhaled Antibiotics, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Inhaled Antibiotics Historical Market Size by Region (2016-2021) 2.3.1 Global Inhaled Antibiotics Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Inhaled Antibiotics Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Inhaled Antibiotics Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Inhaled Antibiotics Sales Forecast by Region (2022-2027) 2.4.2 Global Inhaled Antibiotics Revenue Forecast by Region (2022-2027) 3 Global Inhaled Antibiotics Competitor Landscape by Players 3.1 Global Top Inhaled Antibiotics Manufacturers by Sales 3.1.1 Global Inhaled Antibiotics Sales by Manufacturer (2016-2021) 3.1.2 Global Inhaled Antibiotics Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Inhaled Antibiotics Manufacturers by Revenue 3.2.1 Key Inhaled Antibiotics Manufacturers Covered: Ranking by Revenue 3.2.2 Global Inhaled Antibiotics Revenue by Manufacturers (2016-2021) 3.2.3 Global Inhaled Antibiotics Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Inhaled Antibiotics Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Inhaled Antibiotics Revenue in 2020 3.2.6 Global Inhaled Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Inhaled Antibiotics Price by Manufacturers 3.4 Global Inhaled Antibiotics Manufacturing Base Distribution, Product Types 3.4.1 Inhaled Antibiotics Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Inhaled Antibiotics Product Type 3.4.3 Date of International Manufacturers Enter into Inhaled Antibiotics Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Inhaled Antibiotics Market Size by Type (2016-2021) 4.1.1 Global Inhaled Antibiotics Sales by Type (2016-2021) 4.1.2 Global Inhaled Antibiotics Revenue by Type (2016-2021) 4.1.3 Inhaled Antibiotics Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Inhaled Antibiotics Market Size Forecast by Type (2022-2027) 4.2.1 Global Inhaled Antibiotics Sales Forecast by Type (2022-2027) 4.2.2 Global Inhaled Antibiotics Revenue Forecast by Type (2022-2027) 4.2.3 Inhaled Antibiotics Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Inhaled Antibiotics Market Size by Application (2016-2021) 5.1.1 Global Inhaled Antibiotics Sales by Application (2016-2021) 5.1.2 Global Inhaled Antibiotics Revenue by Application (2016-2021) 5.1.3 Inhaled Antibiotics Price by Application (2016-2021) 5.2 Inhaled Antibiotics Market Size Forecast by Application (2022-2027) 5.2.1 Global Inhaled Antibiotics Sales Forecast by Application (2022-2027) 5.2.2 Global Inhaled Antibiotics Revenue Forecast by Application (2022-2027) 5.2.3 Global Inhaled Antibiotics Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Inhaled Antibiotics Market Size YoY Growth 2016-2027 6.1.1 China Inhaled Antibiotics Sales YoY Growth 2016-2027 6.1.2 China Inhaled Antibiotics Revenue YoY Growth 2016-2027 6.1.3 China Inhaled Antibiotics Market Share in Global Market 2016-2027 6.2 China Inhaled Antibiotics Market Size by Players (International and Local Players) 6.2.1 China Top Inhaled Antibiotics Players by Sales (2016-2021) 6.2.2 China Top Inhaled Antibiotics Players by Revenue (2016-2021) 6.3 China Inhaled Antibiotics Historic Market Review by Type (2016-2021) 6.3.1 China Inhaled Antibiotics Sales Market Share by Type (2016-2021) 6.3.2 China Inhaled Antibiotics Revenue Market Share by Type (2016-2021) 6.3.3 China Inhaled Antibiotics Price by Type (2016-2021) 6.4 China Inhaled Antibiotics Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Inhaled Antibiotics Sales Forecast by Type (2022-2027) 6.4.2 China Inhaled Antibiotics Revenue Forecast by Type (2022-2027) 6.4.3 China Inhaled Antibiotics Price Forecast by Type (2022-2027) 6.5 China Inhaled Antibiotics Historic Market Review by Application (2016-2021) 6.5.1 China Inhaled Antibiotics Sales Market Share by Application (2016-2021) 6.5.2 China Inhaled Antibiotics Revenue Market Share by Application (2016-2021) 6.5.3 China Inhaled Antibiotics Price by Application (2016-2021) 6.6 China Inhaled Antibiotics Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Inhaled Antibiotics Sales Forecast by Application (2022-2027) 6.6.2 China Inhaled Antibiotics Revenue Forecast by Application (2022-2027) 6.6.3 China Inhaled Antibiotics Price Forecast by Application (2022-2027) 7 North America 7.1 North America Inhaled Antibiotics Market Size YoY Growth 2016-2027 7.2 North America Inhaled Antibiotics Market Facts & Figures by Country 7.2.1 North America Inhaled Antibiotics Sales by Country (2016-2021) 7.2.2 North America Inhaled Antibiotics Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Inhaled Antibiotics Market Size YoY Growth 2016-2027 8.2 Asia Pacific Inhaled Antibiotics Market Facts & Figures by Region 8.2.1 Asia Pacific Inhaled Antibiotics Sales by Region (2016-2021) 8.2.2 Asia Pacific Inhaled Antibiotics Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Inhaled Antibiotics Market Size YoY Growth 2016-2027 9.2 Europe Inhaled Antibiotics Market Facts & Figures by Country 9.2.1 Europe Inhaled Antibiotics Sales by Country (2016-2021) 9.2.2 Europe Inhaled Antibiotics Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Inhaled Antibiotics Market Size YoY Growth 2016-2027 10.2 Latin America Inhaled Antibiotics Market Facts & Figures by Country 10.2.1 Latin America Inhaled Antibiotics Sales by Country (2016-2021) 10.2.2 Latin America Inhaled Antibiotics Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Inhaled Antibiotics Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Inhaled Antibiotics Market Facts & Figures by Country 11.2.1 Middle East and Africa Inhaled Antibiotics Sales by Country (2016-2021) 11.2.2 Middle East and Africa Inhaled Antibiotics Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Aradigm 12.1.1 Aradigm Corporation Information 12.1.2 Aradigm Description and Business Overview 12.1.3 Aradigm Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Aradigm Inhaled Antibiotics Products Offered 12.1.5 Aradigm Recent Development 12.2 Gilead Sciences 12.2.1 Gilead Sciences Corporation Information 12.2.2 Gilead Sciences Description and Business Overview 12.2.3 Gilead Sciences Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Gilead Sciences Inhaled Antibiotics Products Offered 12.2.5 Gilead Sciences Recent Development 12.3 Lupin 12.3.1 Lupin Corporation Information 12.3.2 Lupin Description and Business Overview 12.3.3 Lupin Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Lupin Inhaled Antibiotics Products Offered 12.3.5 Lupin Recent Development 12.4 Polyphor 12.4.1 Polyphor Corporation Information 12.4.2 Polyphor Description and Business Overview 12.4.3 Polyphor Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Polyphor Inhaled Antibiotics Products Offered 12.4.5 Polyphor Recent Development 12.5 Insmed Incorporated 12.5.1 Insmed Incorporated Corporation Information 12.5.2 Insmed Incorporated Description and Business Overview 12.5.3 Insmed Incorporated Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Insmed Incorporated Inhaled Antibiotics Products Offered 12.5.5 Insmed Incorporated Recent Development 12.6 Pharmaero 12.6.1 Pharmaero Corporation Information 12.6.2 Pharmaero Description and Business Overview 12.6.3 Pharmaero Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Pharmaero Inhaled Antibiotics Products Offered 12.6.5 Pharmaero Recent Development 12.7 Savara Pharmaceuticals 12.7.1 Savara Pharmaceuticals Corporation Information 12.7.2 Savara Pharmaceuticals Description and Business Overview 12.7.3 Savara Pharmaceuticals Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Savara Pharmaceuticals Inhaled Antibiotics Products Offered 12.7.5 Savara Pharmaceuticals Recent Development 12.8 Joincare Pharmaceutical Group 12.8.1 Joincare Pharmaceutical Group Corporation Information 12.8.2 Joincare Pharmaceutical Group Description and Business Overview 12.8.3 Joincare Pharmaceutical Group Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Joincare Pharmaceutical Group Inhaled Antibiotics Products Offered 12.8.5 Joincare Pharmaceutical Group Recent Development 12.9 Pharmaxis Ltd 12.9.1 Pharmaxis Ltd Corporation Information 12.9.2 Pharmaxis Ltd Description and Business Overview 12.9.3 Pharmaxis Ltd Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Pharmaxis Ltd Inhaled Antibiotics Products Offered 12.9.5 Pharmaxis Ltd Recent Development 12.11 Aradigm 12.11.1 Aradigm Corporation Information 12.11.2 Aradigm Description and Business Overview 12.11.3 Aradigm Inhaled Antibiotics Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Aradigm Inhaled Antibiotics Products Offered 12.11.5 Aradigm Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Inhaled Antibiotics Industry Trends 13.2 Inhaled Antibiotics Market Drivers 13.3 Inhaled Antibiotics Market Challenges 13.4 Inhaled Antibiotics Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Inhaled Antibiotics Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Inhaled Antibiotics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Nebulized Table 3. Major Manufacturers of Dry Powder Table 4. Global Inhaled Antibiotics Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Inhaled Antibiotics Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Inhaled Antibiotics Sales by Regions (2016-2021) & (K Units) Table 7. Global Inhaled Antibiotics Sales Market Share by Regions (2016-2021) Table 8. Global Inhaled Antibiotics Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Inhaled Antibiotics Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Inhaled Antibiotics Sales Market Share Forecast by Region (2022-2027) Table 11. Global Inhaled Antibiotics Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Inhaled Antibiotics Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Inhaled Antibiotics Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Inhaled Antibiotics Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Inhaled Antibiotics Manufacturers by Revenue (US$ Million) in 2020 Table 16. Inhaled Antibiotics Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Inhaled Antibiotics Revenue Share by Manufacturers (2016-2021) Table 18. Global Inhaled Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Inhaled Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Antibiotics as of 2020) Table 20. Key Manufacturers Inhaled Antibiotics Price (2016-2021) (US$/Unit) Table 21. Inhaled Antibiotics Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Inhaled Antibiotics Product Type Table 23. Date of International Manufacturers Enter into Inhaled Antibiotics Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Inhaled Antibiotics Sales by Type (2016-2021) (K Units) Table 26. Global Inhaled Antibiotics Sales Share by Type (2016-2021) Table 27. Global Inhaled Antibiotics Revenue by Type (2016-2021) (US$ Million) Table 28. Global Inhaled Antibiotics Revenue Share by Type (2016-2021) Table 29. Inhaled Antibiotics Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Inhaled Antibiotics Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Inhaled Antibiotics Sales Market Share Forecast by Type (2022-2027) Table 32. Global Inhaled Antibiotics Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Inhaled Antibiotics Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Inhaled Antibiotics Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Inhaled Antibiotics Sales by Application (2016-2021) (K Units) Table 36. Global Inhaled Antibiotics Sales Share by Application (2016-2021) Table 37. Global Inhaled Antibiotics Revenue by Application (2016-2021) (US$ Million) Table 38. Global Inhaled Antibiotics Revenue Share by Application (2016-2021) Table 39. Inhaled Antibiotics Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Inhaled Antibiotics Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Inhaled Antibiotics Sales Market Share Forecast by Application (2022-2027) Table 42. Global Inhaled Antibiotics Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Inhaled Antibiotics Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Inhaled Antibiotics Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. China Inhaled Antibiotics Sales (K Units) of Key Companies (2016-2021) Table 46. China Inhaled Antibiotics Sales Share by Company (2016-2021) Table 47. China Inhaled Antibiotics Revenue (US$ Million) by Company (2016-2021) Table 48. China Inhaled Antibiotics Revenue Share by Company (2016-2021) Table 49. China Inhaled Antibiotics Sales (K Units) by Type (2016-2021) Table 50. China Inhaled Antibiotics Sales Share by Type (2016-2021) Table 51. China Inhaled Antibiotics Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. China Inhaled Antibiotics Price (US$/Unit) by Type (2016-2021) Table 53. China Inhaled Antibiotics Sales (K Units) by Type (2022-2027) Table 54. China Inhaled Antibiotics Sales Share by Type (2022-2027) Table 55. China Inhaled Antibiotics Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. China Inhaled Antibiotics Revenue Share by Type (2022-2027) Table 57. China Inhaled Antibiotics Price (US$/Unit) by Type (2022-2027) Table 58. China Inhaled Antibiotics Sales (K Units) by Application (2016-2021) Table 59. China Inhaled Antibiotics Sales Share by Application (2016-2021) Table 60. China Inhaled Antibiotics Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. China Inhaled Antibiotics Price (US$/Unit) by Application (2016-2021) Table 62. China Inhaled Antibiotics Sales (K Units) by Application (2022-2027) Table 63. China Inhaled Antibiotics Sales Share by Application (2022-2027) Table 64. China Inhaled Antibiotics Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. China Inhaled Antibiotics Revenue Share by Application (2022-2027) Table 66. China Inhaled Antibiotics Price (US$/Unit) by Application (2022-2027) Table 67. North America Inhaled Antibiotics Sales by Country (2016-2021) & (K Units) Table 68. North America Inhaled Antibiotics Sales Market Share by Country (2016-2021) Table 69. North America Inhaled Antibiotics Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Inhaled Antibiotics Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Inhaled Antibiotics Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Inhaled Antibiotics Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Inhaled Antibiotics Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Inhaled Antibiotics Revenue Market Share by Region (2016-2021) Table 75. Europe Inhaled Antibiotics Sales by Country (2016-2021) & (K Units) Table 76. Europe Inhaled Antibiotics Sales Market Share by Country (2016-2021) Table 77. Europe Inhaled Antibiotics Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Inhaled Antibiotics Revenue Market Share by Country (2016-2021) Table 79. Latin America Inhaled Antibiotics Sales by Country (2016-2021) & (K Units) Table 80. Latin America Inhaled Antibiotics Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Inhaled Antibiotics Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Inhaled Antibiotics Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Inhaled Antibiotics Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Inhaled Antibiotics Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Inhaled Antibiotics Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Inhaled Antibiotics Revenue Market Share by Country (2016-2021) Table 87. Aradigm Corporation Information Table 88. Aradigm Description and Business Overview Table 89. Aradigm Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. Aradigm Inhaled Antibiotics Product Table 91. Aradigm Recent Development Table 92. Gilead Sciences Corporation Information Table 93. Gilead Sciences Description and Business Overview Table 94. Gilead Sciences Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Gilead Sciences Product Table 96. Gilead Sciences Recent Development Table 97. Lupin Corporation Information Table 98. Lupin Description and Business Overview Table 99. Lupin Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Lupin Product Table 101. Lupin Recent Development Table 102. Polyphor Corporation Information Table 103. Polyphor Description and Business Overview Table 104. Polyphor Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. Polyphor Product Table 106. Polyphor Recent Development Table 107. Insmed Incorporated Corporation Information Table 108. Insmed Incorporated Description and Business Overview Table 109. Insmed Incorporated Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. Insmed Incorporated Product Table 111. Insmed Incorporated Recent Development Table 112. Pharmaero Corporation Information Table 113. Pharmaero Description and Business Overview Table 114. Pharmaero Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Pharmaero Product Table 116. Pharmaero Recent Development Table 117. Savara Pharmaceuticals Corporation Information Table 118. Savara Pharmaceuticals Description and Business Overview Table 119. Savara Pharmaceuticals Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Savara Pharmaceuticals Product Table 121. Savara Pharmaceuticals Recent Development Table 122. Joincare Pharmaceutical Group Corporation Information Table 123. Joincare Pharmaceutical Group Description and Business Overview Table 124. Joincare Pharmaceutical Group Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Joincare Pharmaceutical Group Product Table 126. Joincare Pharmaceutical Group Recent Development Table 127. Pharmaxis Ltd Corporation Information Table 128. Pharmaxis Ltd Description and Business Overview Table 129. Pharmaxis Ltd Inhaled Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Pharmaxis Ltd Product Table 131. Pharmaxis Ltd Recent Development Table 132. Inhaled Antibiotics Market Trends Table 133. Inhaled Antibiotics Market Drivers Table 134. Inhaled Antibiotics Market Challenges Table 135. Inhaled Antibiotics Market Restraints Table 136. Inhaled Antibiotics Customers List Table 137. Inhaled Antibiotics Distributors List Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Inhaled Antibiotics Product Picture Figure 2. Global Inhaled Antibiotics Sales Market Share by Type in 2020 & 2027 Figure 3. Nebulized Product Picture Figure 4. Dry Powder Product Picture Figure 5. Global Inhaled Antibiotics Sales Market Share by Application in 2020 & 2027 Figure 6. Ventilator-associated Pneumonia Figure 7. Ventilator-associated Bronchitis Figure 8. Others Figure 9. Inhaled Antibiotics Report Years Considered Figure 10. Global Inhaled Antibiotics Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Inhaled Antibiotics Market Size 2016-2027 (US$ Million) Figure 12. Global Inhaled Antibiotics Sales 2016-2027 (K Units) Figure 13. Global Inhaled Antibiotics Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Inhaled Antibiotics Sales Market Share by Region (2016-2021) Figure 15. Global Inhaled Antibiotics Sales Market Share by Region in 2020 Figure 16. Global Inhaled Antibiotics Revenue Market Share by Region (2016-2021) Figure 17. Global Inhaled Antibiotics Revenue Market Share by Region in 2020 Figure 18. Global Inhaled Antibiotics Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Inhaled Antibiotics Revenue in 2020 Figure 20. Inhaled Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Inhaled Antibiotics Sales Market Share by Type (2016-2021) Figure 22. Global Inhaled Antibiotics Sales Market Share by Type in 2020 Figure 23. Global Inhaled Antibiotics Revenue Market Share by Type (2016-2021) Figure 24. Global Inhaled Antibiotics Revenue Market Share by Type in 2020 Figure 25. Global Inhaled Antibiotics Sales Market Share by Application (2016-2021) Figure 26. Global Inhaled Antibiotics Sales Market Share by Application in 2020 Figure 27. Global Inhaled Antibiotics Revenue Market Share by Application (2016-2021) Figure 28. Global Inhaled Antibiotics Revenue Market Share by Application in 2020 Figure 29. China Inhaled Antibiotics Sales Growth Rate 2016-2027 (K Units) Figure 30. China Inhaled Antibiotics Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China Inhaled Antibiotics Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest Inhaled Antibiotics Players Market Share by Revenue in Inhaled Antibiotics in 2020 Figure 33. China Inhaled Antibiotics Revenue Share by Type (2016-2021) Figure 34. China Inhaled Antibiotics Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China Inhaled Antibiotics Revenue Share by Application (2016-2021) Figure 36. China Inhaled Antibiotics Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Inhaled Antibiotics Sales Growth Rate 2016-2021 (K Units) Figure 38. North America Inhaled Antibiotics Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Inhaled Antibiotics Sales Market Share by Country in 2020 Figure 40. North America Inhaled Antibiotics Revenue Market Share by Country in 2020 Figure 41. U.S. Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 42. U.S. Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 44. Canada Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Inhaled Antibiotics Sales Growth Rate 2016-2021 (K Units) Figure 46. Europe Inhaled Antibiotics Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Inhaled Antibiotics Sales Market Share by Country in 2020 Figure 48. Europe Inhaled Antibiotics Revenue Market Share by Country in 2020 Figure 49. Germany Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 50. Germany Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 52. France Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 54. U.K. Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 56. Italy Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 58. Russia Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Inhaled Antibiotics Sales Growth Rate 2016-2021 (K Units) Figure 60. Asia Pacific Inhaled Antibiotics Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Inhaled Antibiotics Sales Market Share by Region in 2020 Figure 62. Asia Pacific Inhaled Antibiotics Revenue Market Share by Region in 2020 Figure 63. China Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 64. China Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 66. Japan Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 68. South Korea Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 70. India Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 72. Australia Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 74. Taiwan Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 76. Indonesia Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 78. Thailand Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 80. Malaysia Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 82. Philippines Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 84. Vietnam Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Inhaled Antibiotics Sales Growth Rate 2016-2021 (K Units) Figure 86. Latin America Inhaled Antibiotics Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Inhaled Antibiotics Sales Market Share by Country in 2020 Figure 88. Latin America Inhaled Antibiotics Revenue Market Share by Country in 2020 Figure 89. Mexico Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 90. Mexico Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 92. Brazil Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 94. Argentina Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Inhaled Antibiotics Sales Growth Rate 2016-2021 (K Units) Figure 96. Middle East and Africa Inhaled Antibiotics Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Inhaled Antibiotics Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Inhaled Antibiotics Revenue Market Share by Country in 2020 Figure 99. Turkey Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 100. Turkey Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 102. Saudi Arabia Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Inhaled Antibiotics Sales Growth Rate (2016-2021) (K Units) Figure 104. UAE Inhaled Antibiotics Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Inhaled Antibiotics Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Aradigm Gilead Sciences Lupin Polyphor Insmed Incorporated Pharmaero Savara Pharmaceuticals Joincare Pharmaceutical Group Pharmaxis Ltd